Department of Molecular and Cellular Biology, College of Biological Sciences, University of Guelph, Guelph, Ontario, Canada.
Ann N Y Acad Sci. 2022 Sep;1515(1):75-96. doi: 10.1111/nyas.14807. Epub 2022 Jun 15.
Staphylococcus aureus is a pathobiont capable of colonizing and infecting most tissues within the human body, resulting in a multitude of different clinical outcomes. Adhesion of S. aureus to the host is crucial for both host colonization and the establishment of infections. Underlying the pathogen's success is a complex and diverse arsenal of adhesins. In this review, we discuss the different classes of adhesins, including a consideration of the various adhesion sites throughout the body and the clinical outcomes of each infection type. The development of therapeutics targeting the S. aureus host-pathogen interaction is a relatively understudied area. Due to the increasing global threat of antimicrobial resistance, it is crucial that innovative and alternative approaches are considered. Neutralizing virulence factors, through the development of antivirulence agents, could reduce bacterial pathogenicity and the ever-increasing burden of S. aureus infections. This review provides insight into potentially efficacious adhesion-associated targets for the development of novel decolonizing and antivirulence strategies.
金黄色葡萄球菌是一种能够定植和感染人体大多数组织的条件致病菌,可导致多种不同的临床结果。金黄色葡萄球菌与宿主的黏附对于宿主定植和感染的建立至关重要。该病原体成功的基础是其具有复杂多样的黏附素。在这篇综述中,我们讨论了不同类别的黏附素,包括对全身各种黏附部位的考虑以及每种感染类型的临床结果。针对金黄色葡萄球菌与宿主-病原体相互作用的治疗方法的开发是一个相对研究不足的领域。由于全球对抗微生物药物耐药性的威胁日益增加,因此必须考虑采用创新和替代方法。通过开发抗毒力药物来中和毒力因子可能会降低细菌的致病性和金黄色葡萄球菌感染的日益加重的负担。本综述为开发新型去定植和抗毒力策略提供了有关潜在有效的黏附相关靶标的见解。